Autologous tumor lysate-loaded dendritic cell vaccination used in combination with standard-of-care treatment extended overall survival for patients with newly diagnosed glioblastoma as well as those with recurrent disease. #btsm#oncology
Treatment with the investigative AVA6000 peptide drug conjugate consisting of doxorubicin led to clinically meaningful tumor shrinkage in patients with FAP–positive salivary gland cancer.
#hncsm#oncology#MedTwitterhubs.li/Q035jRx50
Preliminary data show that AVA6000 led to robust and clinically meaningful tumor shrinkage in patients with salivary gland cancer.
#hncsm#oncology#MedTwitter